Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

Integrin alphavbeta6 is important for wound healing and hair growth, and blocking it may improve these processes.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

rPanglaoDB helps study rare cell types by merging RNA data, confirming fibrocytes' role in healing.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Minoxidil might partially activate estrogen receptors, affecting hair growth.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Red fox, golden jackal, and gray wolf hairs have similar features but differ in length, thickness, and inner structure.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Ritlecitinib is safe for treating alopecia areata for up to 48 weeks.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

DP cells interact with immune cells, possibly causing hair loss in Alopecia Areata.